Breaking News Instant updates and real-time market news.

BYSI

BeyondSpring

$29.00

-1.239 (-4.10%)

04:55
12/20/17
12/20
04:55
12/20/17
04:55

BeyondSpring management to meet with Seaport Global

Meeting to be held in New York on December 20 hosted by Seaport Global.

  • 20

    Dec

BYSI BeyondSpring
$29.00

-1.239 (-4.10%)

07/14/17
RODM
07/14/17
NO CHANGE
Target $50
RODM
Buy
BeyondSpring price target raised to $50 from $43 at Rodman & Renshaw
Rodman & Renshaw analyst Joseph Pantginis raised his price target for BeyondSpring to $50 after increasing his projected chance of success for neutropenia to 55% from 50%. The analyst admits, however, that upcoming data and the share lockup expiration "could make September quite volatile." Pantginis keeps a Buy rating on the shares.
08/22/17
MAXM
08/22/17
INITIATION
Target $52
MAXM
Buy
BeyondSpring initiated with a Buy at Maxim
Maxim analyst Gabrielle Zhou started BeyondSpring with a Buy rating and $52 price target, stating that the company's unique small molecule to prevent chemotherapy-induced neutropenia has the potential to become the new standard of care for chemotherapy patients.
10/26/17
HCWC
10/26/17
NO CHANGE
Target $60
HCWC
Buy
BeyondSpring price target raised to $60 from $50 at H.C. Wainwright
H.C. Wainwright analyst Joseph Pantginis raised his price target for BeyondSpring to $60 saying new regulatory rules in China may accelerate Plinabulin approval. The CPC Central Committee and State Council of China's new regulatory guidelines should be beneficial to BeyondSpring by accelerating approval and extending intellectual property protection, Pantginis tells investors in a research note. He keeps a Buy rating o the shares.
12/05/17
GHSC
12/05/17
INITIATION
Target $56
GHSC
Buy
BeyondSpring initiated with a Buy at Seaport Global
Seaport Global analyst Vernon Bernardino initiated BeyondSpring with a Buy and $56 price target saying its lead drug, Plinabulin, is a differentiated standard in the potential treatment option for chemotherapy-induced neutropenia (CIN). He thinks Plinabulin could also play a key role in improving results with traditional cancer drugs and immunotherapies that are limited by their significant toxicities.

TODAY'S FREE FLY STORIES

DPZ

Domino's Pizza

$283.74

1.74 (0.62%)

07:33
07/19/18
07/19
07:33
07/19/18
07:33
Hot Stocks
Domino's Pizza reports Q2 domestic SSS up 6.9% »

Reports Q2 international…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 21

    Sep

  • 05

    Oct

MNK

Mallinckrodt

$21.81

0.19 (0.88%)

07:33
07/19/18
07/19
07:33
07/19/18
07:33
Recommendations
Mallinckrodt analyst commentary  »

Mallinckrodt price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Aug

  • 08

    Aug

  • 09

    Aug

  • 13

    Aug

  • 22

    Aug

STBA

S&T Bancorp

$43.96

0.19 (0.43%)

07:33
07/19/18
07/19
07:33
07/19/18
07:33
Earnings
S&T Bancorp reports Q2 EPS 61c, consensus 61c »

Reports Q2 NIM 3.64%.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

ONDK

On Deck Capital

$8.09

0.6 (8.01%)

07:32
07/19/18
07/19
07:32
07/19/18
07:32
Downgrade
On Deck Capital rating change  »

Morgan Stanley sees On…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Aug

  • 08

    Aug

  • 15

    Aug

  • 16

    Aug

ADS

Alliance Data

$226.51

1.13 (0.50%)

07:32
07/19/18
07/19
07:32
07/19/18
07:32
Earnings
Breaking Earnings news story on Alliance Data »

Alliance Data backs FY18…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 08

    Aug

ADS

Alliance Data

$226.51

1.13 (0.50%)

07:31
07/19/18
07/19
07:31
07/19/18
07:31
Earnings
Alliance Data backs FY18 core EPS view $22.50 to $23.00, consensus $22.57 »

CEO Heffernan continued:…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 08

    Aug

DPZ

Domino's Pizza

$283.74

1.74 (0.62%)

07:31
07/19/18
07/19
07:31
07/19/18
07:31
Earnings
Domino's Pizza reports Q2 adjusted EPS $1.84, consensus $1.75 »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 21

    Sep

  • 05

    Oct

ADS

Alliance Data

$226.51

1.13 (0.50%)

07:30
07/19/18
07/19
07:30
07/19/18
07:30
Earnings
Alliance Data reports Q2 core EPS $5.01, consensus $4.66 »

Reports Q2 revenue $1.9B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 08

    Aug

LONE

Lonestar Resources

$10.37

0.42 (4.22%)

07:30
07/19/18
07/19
07:30
07/19/18
07:30
Initiation
Lonestar Resources initiated  »

Lonestar Resources…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Aug

CMCSA

Comcast

$34.03

-0.23 (-0.67%)

, FOXA

21st Century Fox

$46.69

0.22 (0.47%)

07:30
07/19/18
07/19
07:30
07/19/18
07:30
Options
Unusual put flow in option market yesterday »

Notable put activity was…

CMCSA

Comcast

$34.03

-0.23 (-0.67%)

FOXA

21st Century Fox

$46.69

0.22 (0.47%)

GM

General Motors

$39.87

-0.185 (-0.46%)

PZZA

Papa John's

$53.60

2.06 (4.00%)

HPQ

HP Inc.

$23.54

-0.06 (-0.25%)

GOGO

Gogo

$3.91

0.15 (3.99%)

MDR

McDermott

$17.97

-0.075 (-0.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 27

    Jul

  • 31

    Jul

SQ

Square

$68.30

-0.02 (-0.03%)

07:28
07/19/18
07/19
07:28
07/19/18
07:28
Upgrade
Square rating change  »

Square upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

  • 15

    Aug

  • 16

    Aug

MEET

Meet Group

$4.14

0.08 (1.97%)

07:26
07/19/18
07/19
07:26
07/19/18
07:26
Upgrade
Meet Group rating change  »

Meet Group upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRN

Amarin

$2.86

-0.1 (-3.38%)

07:26
07/19/18
07/19
07:26
07/19/18
07:26
Recommendations
Amarin analyst commentary  »

Amarin's Vascepa…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JPM

JPMorgan

$111.52

1.01 (0.91%)

07:25
07/19/18
07/19
07:25
07/19/18
07:25
Upgrade
JPMorgan rating change  »

JPMorgan upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Oct

EBAY

eBay

$37.95

0.13 (0.34%)

07:25
07/19/18
07/19
07:25
07/19/18
07:25
Recommendations
eBay analyst commentary  »

eBay price target lowered…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FFIV

F5 Networks

$179.52

2.86 (1.62%)

07:24
07/19/18
07/19
07:24
07/19/18
07:24
Downgrade
F5 Networks rating change  »

Morgan Stanley sees risk…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 08

    Aug

CMG

Chipotle

$453.56

0.77 (0.17%)

, SBUX

Starbucks

$51.15

-0.12 (-0.23%)

07:24
07/19/18
07/19
07:24
07/19/18
07:24
Recommendations
Chipotle, Starbucks analyst commentary  »

Wedbush cautious on…

CMG

Chipotle

$453.56

0.77 (0.17%)

SBUX

Starbucks

$51.15

-0.12 (-0.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 26

    Jul

PTCT

PTC Therapeutics

$35.02

-0.19 (-0.54%)

07:23
07/19/18
07/19
07:23
07/19/18
07:23
Initiation
PTC Therapeutics initiated  »

PTC Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HRTX

Heron Therapeutics

$37.75

-0.35 (-0.92%)

07:22
07/19/18
07/19
07:22
07/19/18
07:22
Recommendations
Heron Therapeutics analyst commentary  »

Heron Therapeutics price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MTB

M&T Bank

$174.38

5.77 (3.42%)

07:20
07/19/18
07/19
07:20
07/19/18
07:20
Recommendations
M&T Bank analyst commentary  »

M&T Bank price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:20
07/19/18
07/19
07:20
07/19/18
07:20
General news
Treasury Market Outlook: Treasury yields have extended slightly higher »

Treasury Market Outlook:…

WRD

WildHorse Resource

07:19
07/19/18
07/19
07:19
07/19/18
07:19
Initiation
WildHorse Resource initiated  »

WildHorse Resource…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

  • 19

    Aug

ARA

American Renal Associates

07:19
07/19/18
07/19
07:19
07/19/18
07:19
Initiation
American Renal Associates initiated  »

American Renal Associates…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BIG

Big Lots

$42.76

0.39 (0.92%)

07:19
07/19/18
07/19
07:19
07/19/18
07:19
Initiation
Big Lots initiated  »

Big Lots initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:18
07/19/18
07/19
07:18
07/19/18
07:18
General news
Futures lower as trade war rhetoric, earnings reporting continues »

Stock futures are…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.